Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;101(2):659-68.
doi: 10.1210/jc.2015-3169. Epub 2015 Dec 16.

Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk

Affiliations

Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk

Aaron Leong et al. J Clin Endocrinol Metab. 2016 Feb.

Abstract

Context: Although clinical trials have shown that hypoglycemia is associated with coronary artery disease (CAD), little is known whether hypoglycemia is a CAD risk factor in primary care.

Objective: We sought to determine whether previous hypoglycemia was associated with incident CAD, and whether this association differed in patients of different underlying vascular risk.

Design, setting and participants: This is a longitudinal cohort study of diabetes patients without CAD before January 1, 2006 (n = 9173) followed at an academic network of 13 primary care practices from January 1, 2006 to June 30, 2012. Hypoglycemic events before January 1, 2006 were identified via International Classification of Diseases Ninth Revision codes from emergency department, inpatient and outpatient visits.

Main outcome measure: Patients were followed until incident CAD or June 30, 2012. Cox regression with time interaction was used to determine the association between hypoglycemia and CAD (significance set at P ≤ .05). We then tested the association among high vascular risk patients (age ≥ 55 y, hemoglobin A1c ≥ 7.5%, ≥2 risk factors [dyslipidemia, hypertension or obesity]), a subset of high vascular risk patients aged 65 years or older, and the remaining patients with lower vascular risk.

Results: Three percent of patients (n = 285) had previous hypoglycemia. Hypoglycemia was associated with a 2-fold CAD risk (hazard ratio [HR] 2.15; 95% confidence interval [95%CI] 1.24-3.74), adjusting for time interaction and vascular risk factors. Among high vascular risk patients, the risk was 3-fold (HR 3.01 [95%CI 1.15-7.91], n = 1823 [20% of cohort]), and over 4-fold (HR 4.62 [95%CI 1.65-12.9], n = 996) in the subset aged more than or equal to 65 years. No association was found in the remaining 80% of the cohort with lower vascular risk.

Conclusions: Previous hypoglycemia was associated with CAD among high vascular risk patients. Hypoglycemia may not be a CAD risk factor for the majority of primary care patients with lower underlying vascular risk.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Hazard ratios of hypoglycemia on incident CAD in the entire cohort and in different vascular risk groups. The univariable model included hypoglycemia and a time varying covariate. The CAD risk factor (CAD RF)-adjusted model additionally included age, sex, race/ethnicity, educational attainment, hypertension, dyslipidemia, diabetes duration, BMI, and HbA1c. The fully adjusted model additionally adjusted for LDL, HDL, eGFR, retinopathy, neuropathy and renal failure, cancer, dementia, dysrhythmias, insulin, and sulfonylurea exposure, 3 or more classes of antidiabetic agents, chronic medication count, more than or equal to 5% weight loss within a year, hospitalizations, and 2 or more HbA1c measurements per year.
Figure 2.
Figure 2.
Cumulative hazard estimates of hypoglycemia on incident CAD in the entire cohort and in different vascular risk groups. Log rank test was statistically significant for patients age 65 years or older, high vascular risk subgroup (P = .022). Log rank tests were not statistically significant for the entire cohort, P = .450, low vascular risk group, P = .928, and high vascular risk group, P = .095.

References

    1. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–1589. - PubMed
    1. ACCORD Study Group, Gerstein HC, Miller ME, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818–828. - PMC - PubMed
    1. ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572. - PubMed
    1. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–139. - PubMed
    1. ORIGIN Trial Investigators, Gerstein HC, Bosch J, et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012;367:319–328. - PubMed

Publication types

MeSH terms

Substances